بدائل البحث:
significant degs » significant genes (توسيع البحث), significant adverse (توسيع البحث), significant cause (توسيع البحث)
significant nn » significant non (توسيع البحث), significant ns (توسيع البحث), significant new (توسيع البحث)
degs increase » drugs increased (توسيع البحث), peaks increase (توسيع البحث), bems increased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
significant degs » significant genes (توسيع البحث), significant adverse (توسيع البحث), significant cause (توسيع البحث)
significant nn » significant non (توسيع البحث), significant ns (توسيع البحث), significant new (توسيع البحث)
degs increase » drugs increased (توسيع البحث), peaks increase (توسيع البحث), bems increased (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
-
1
-
2
The profile of the 263 significant differentially expressed metabolites (DEMs).
منشور في 2021الموضوعات: -
3
-
4
-
5
Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).
منشور في 2024"…<p>Gene set enrichment analysis with identified DEG (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s compared to unstimulated ILC2s (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…"
-
6
-
7
-
8
-
9
-
10
-
11
-
12
Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP<sub>2</sub> antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).
منشور في 2024"…<p>Gene set enrichment analysis with identified DEGs (|log2FC| ≥ 0.58, adj. p-value ≤ 0.05) of metabolite activated ILC2s pre-incubated with the selective DP<sub>2</sub> antagonist fevipiprant compared to metabolite activated ILC2s without fevipiprant stimulation (red = upregulated pathways, blue = downregulated pathways, increasing circle size corresponds to increasing significance).…"
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20